Caffeine intake induces an alteration in human neutrophil A2A adenosine receptors

Cellular and Molecular Life Sciences

Volumn 62, Issue 19-20, 2005, Pages 2350-2358

  Varani, K ^a   Portaluppi, F ^a   Gessi, S ^a   Merighi, S ^a   Vincenzi, F ^a   Cattabriga, E ^a   Dalpiaz, A ^a   Bortolotti, F ^a   Belardinelli, L ^b   Borea, P A ^a  

^a Pharmacology Unit   (Italy)

^b CV THERAPEUTICS INC   (United States)

Author keywords

Adenosine receptors; Binding assays; Caffeine; Cyclic AMP; Human neutrophils; Superoxide anion production

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; CAFFEINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOACCUMULATION; CHRONIC DRUG ADMINISTRATION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN CELL; MALE; NEUTROPHIL; NORMAL HUMAN; PROTEIN FUNCTION; RECEPTOR AFFINITY; RECEPTOR DENSITY;

ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ADULT; CAFFEINE; CELLS, CULTURED; CYCLIC AMP; HUMANS; MALE; NEUTROPHILS; RECEPTOR, ADENOSINE A2A; SUPEROXIDES;

EID: 27144469330     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-005-5312-z     Document Type: Article

References (40)

1. Fredholm B. B., Battig K., Holmen J., Nehlig A. and Zvartau E. E. (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51: 83-133
2. Mandel H. G. (2002) Update on caffeine consumption, disposition and action. Food Chem. Toxicol. 40: 1231-1234
3. Fredholm B. B., Ijzerman A.P., Jacobson K. A., Klotz K. N. and Linden J. (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 50: 527-552
4. Thong F. S. L. and Graham T. E. (2002) The putative roles of adenosine in insulin and exercise mediated regulation of glucose transport and glycogen metabolism in skeletal muscle. Can. J. Appl. Physiol. 27: 152-178
5. Graham T. E. (2001) Caffeine and exercise: metabolism, endurance and performance. Sports Med. 31: 785-807
6. 2A receptor gene polymorphisms and caffeine induced anxiety. Neuropsychopharmacology 2: 1694-1702
7. Fredholm B. B. (1998) Adenosine, adenosine receptors and the actions of caffeine. Pharmacol. Toxicol. 76: 93-101
8. Ross G. W., Abbott R. D., Petrovitch H., White L. R. and Tanner C. M. (2000) Relationship between caffeine intake and Parkinson disease. JAMA 284: 1378-1379
9. White P. J. and Nguyen T. T. (2002) Chronic caffeine treatment causes changes in cardiac adenosine receptor function in rats. Pharmacology 65: 129-135
10. Aqel R. A., Zoghbi G. J. and Trimm J. R. (2004) Effect of caffeine administered intravenously on intracoronary-administered adenosine-induced coronary hemodynamics in patients with coronary artery disease. Am. J. Cardiol. 93: 434-446
11. Myers M. C. (2004) Effect of caffeine on blood pressure beyond the laboratory. Hypertension 43: 724-725
12. 2A adenosine receptors in human neutrophil membranes. Br. J. Pharmacol. 123: 1723-1731
13. 2A adenosine receptors in human peripheral blood cells. Br. J. Pharmacol. 129: 2-11
14. 2A adenosine receptor mediates coronary vasodilation. J. Pharmacol. Exp. Ther. 284: 1066-1073
15. Grobbee D. E., Rimm E. B., Giovannucci E., Colditz G., Stampfer M. and Willet W. (1990) Coffee, caffeine, and cardiovascular disease in men. N. Engl. J. Med. 323: 1026-1032
16. 2A adenosine receptor in primary human endothelial cells. J. Biol. Chem. 272: 5792-5799
17. 2A adenosine receptors in chronic heart failure and cardiac transplantation. FASEB J. 17: 280-282
18. Biaggioni I., Paul S., Puckett A. and Arzubiaga C. (1991) Caffeine and theophylline as adenosine receptor antagonists in humans. J. Pharmacol. Exp. Ther. 258: 588-593
19. 2A adenosine receptors and their function in human platelets. Circulation 99: 2499-2502
20. 2A receptors: functional and biochemical aspects. Circulation 102: 285-289
21. Montesinos M. C., Yap J. S., Desai A., Posadas I., McCrary C. T. and Cronstein B. N. (2000) Reversal of the anti-inflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: evidence that the anti-inflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant arthritis. Arthritis Rheum. 43: 663-665
22. 2A receptors in downregulation of inflammation and immunity in the pathogenesis of infection diseases. Microbes Infect. 5: 515-526
23. 2A adenosine receptors to engineer inflammation in vivo. J. Biochem. Cell Biol. 35: 410-414
24. Horrigan L. A., Kelly J. P. and Connor T. J. (2004) Caffeine suppresses TNF-α production via activation of the cyclic AMP/protein kinase A pathway. Intern. Immunopharm. 4: 1409-1417
25. Jafari M. and Rabbani A. (2004) Studies on the mechanism of caffeine action in alveolar macrophages: caffeine elevates cyclic adenosine monophosphate level and prostaglandin synthesis. Metabolism 253: 687-692
26. Bradford M. M. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding. Anal. Biochem. 72: 248
27. Higuchi R., Fockler C., Dollinger G. and Watson R. (1993) Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology 11: 1026-1030
28. Munson P. J. and Rodbard D. (1980) Ligand: a versatile computerized approach for the characterization of ligand binding systems. Anal. Biochem. 107: 220-239
29. Notarius C. F. (2003) Caffeine and coffee tolerance. Circulation 108: 38-40
30. 2A adenosine receptors and mRNA in mouse brain: effect of long term caffeine treatment. Brain Res. 762: 153-164
31. Paul S., Kurunwune B. and Biaggioni I. (1993) Caffeine withdrawal: apparent heterologous sensitization to adenosine and prostacyclin actions in human platelets. J. Pharmacol. Exp. Ther. 267: 838-843
32. 1 adenosine receptor up-regulation and activation attenuates meuroinflammation and demyelination in a model of multiple sclerosis. J. Neurosci. 24: 1521-1529
33. Conlay L. A., Conant A. J., deBros F. and Wurtman R. (1997) Caffeine alters plasma adenosine levels. Nature 389: 136
34. Kinsel J. F. and Sitkovsky M. V. (2003) Possible targeting of G protein coupled receptor to manipulate inflammation in vivo using synthetic and natural ligands. Ann. Rheum. Dis 62: 22-24
35. Feldman M., Brennan F. M. and Maini R. N. (1996) Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 5: 195-202
36. Dal Canto R. A., Shaw M. K., Nolan G. P., Steinman L. and Fathman C. G. (1999) Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis. Clin. Immunol. 90: 10-14
37. Maia L. and De Mendonca A. (2002) Does caffeine intake protect from Alzheimer's disease? Eur. J. Neurol. 9: 377-382
38. Sliwa K., Woodiwiss A., Candy G., Badenhorst D., Libhaber C., Norton G. et al. (2002) Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompenstaed congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am. J. Cardiol. 90: 1118-1122
39. Petrie H. J., Chown S. E., Belfie L. M., Duncan A. M., McLaren D. H., Conquer J. A. et al. (2004) Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss. Am. J. Clin. Nutr. 80: 22-28
40. 1 mRNA in mouse brain: effect of long term caffeine treatment. Brain Res. 762: 153-164